Influence of NK cell magnetic bead isolation methods on phenotype and function of murine NK cells

Journal of Immunological Methods

Volumn 378, Issue 1-2, 2012, Pages 1-10

  Meinhardt, Kathrin ^a   Kroeger, Irena ^a   Abendroth, Alexandra ^a   Müller, Sabine ^b   Mackensen, Andreas ^a   Ullrich, Evelyn ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b MILTENYI BIOTEC GMBH   (Germany)

Author keywords

DX5; MACS; Natural killer cells; NK cell isolation; NK cell subsets; NKp46

Indexed keywords

ALPHA2 INTEGRIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; LYMPHOCYTE DEPLETION; LYMPHOCYTE FUNCTION; MAGNETIC BEAD ISOLATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PURIFICATION; SPLEEN CELL;

ANIMALS; B-LYMPHOCYTES; CELL SEPARATION; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; IMMUNOMAGNETIC SEPARATION; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MAGNETICS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROSPHERES; PHENOTYPE; SPLEEN; TISSUE THERAPY;

MURINAE; MUS;

EID: 84859425721     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2012.01.008     Document Type: Article

References (20)

1. Arase H., Arase N., Saito T. Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. J. Exp. Med. 1996, 183:2391.
2. Arase H., Saito T., Phillips J.H., Lanier L.L. Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J. Immunol. 2001, 167:1141.
3. Bonnotte B., Larmonier N., Favre N., Fromentin A., Moutet M., Martin M., Gurbuxani S., Solary E., Chauffert B., Martin F. Identification of tumor-infiltrating macrophages as the killers of tumor cells after immunization in a rat model system. J. Immunol. 2001, 167:5077.
4. Carlyle J.R., Mesci A., Ljutic B., Belanger S., Tai L.H., Rousselle E., Troke A.D., Proteau M.F., Makrigiannis A.P. Molecular and genetic basis for strain-dependent NK1.1 alloreactivity of mouse NK cells. J. Immunol. 2006, 176:7511.
5. Charbonnier L.M., van Duivenvoorde L.M., Apparailly F., Cantos C., Han W.G., Noel D., Duperray C., Huizinga T.W., Toes R.E., Jorgensen C., Louis-Plence P. Immature dendritic cells suppress collagen-induced arthritis by in vivo expansion of CD49b+ regulatory T cells. J. Immunol. 2006, 177:3806.
6. DeHart S.L., Heikens M.J., Tsai S. Jagged2 promotes the development of natural killer cells and the establishment of functional natural killer cell lines. Blood 2005, 105:3521.
7. Gruetzkau A., Radbruch A. Small but mighty: how the MACS-technology based on nanosized superparamagnetic particles has helped to analyze the immune system within the last 20years. Cytometry A 2010, 77:643.
8. Hayakawa Y., Smyth M.J. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 2006, 176:1517.
9. Hayakawa Y., Huntington N.D., Nutt S.L., Smyth M.J. Functional subsets of mouse natural killer cells. Immunol. Rev. 2006, 214:47.
10. Kiessling R., Klein E., Wigzell H. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 1975, 5:112.
11. Ljunggren H.G., Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 1990, 11:237.
12. McCartney S., Vermi W., Gilfillan S., Cella M., Murphy T.L., Schreiber R.D., Murphy K.M., Colonna M. Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells. J. Exp. Med. 2009, 206:2967.
13. McKenna D.H., Sumstad D., Bostrom N., Kadidlo D.M., Fautsch S., McNearney S., Dewaard R., McGlave P.B., Weisdorf D.J., Wagner J.E., McCullough J., Miller J.S. Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience. Transfusion 2007, 47:520.
14. Meyer-Monard S., Passweg J., Siegler U., Kalberer C., Koehl U., Rovo A., Halter J., Stern M., Heim D., Alois Gratwohl J.R., Tichelli A. Clinical-grade purification of natural killer cells in haploidentical hematopoietic stem cell transplantation. Transfusion 2009, 49:362.
15. Miltenyi S., Muller W., Weichel W., Radbruch A. High gradient magnetic cell separation with MACS. Cytometry 1990, 11:231.
16. Rosmaraki E.E., Douagi I., Roth C., Colucci F., Cumano A., Di Santo J.P. Identification of committed NK cell progenitors in adult murine bone marrow. Eur. J. Immunol. 2001, 31:1900.
17. Sivori S., Vitale M., Morelli L., Sanseverino L., Augugliaro R., Bottino C., Moretta L., Moretta A. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J. Exp. Med. 1997, 186:1129.
18. Terme M., Ullrich E., Delahaye N.F., Chaput N., Zitvogel L. Natural killer cell-directed therapies: moving from unexpected results to successful strategies. Nat. Immunol. 2008, 9:486.
19. Vosshenrich C.A., Lesjean-Pottier S., Hasan M., Richard-Le Goff O., Corcuff E., Mandelboim O., Di Santo J.P. CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells. J. Exp. Med. 2007, 204:2569.
20. Walzer T., Blery M., Chaix J., Fuseri N., Chasson L., Robbins S.H., Jaeger S., Andre P., Gauthier L., Daniel L., Chemin K., Morel Y., Dalod M., Imbert J., Pierres M., Moretta A., Romagne F., Vivier E. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:3384.